Tony12
Lv41
460 积分
2024-05-23 加入
-
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
1小时前
已完结
-
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
2天前
已完结
-
[89Zr]Zr-girentuximab PET-CT imaging to diagnose, characterize, and differentiate clear-cell renal cell carcinoma
11天前
已关闭
-
The non-small-cell lung cancer drug market
11天前
已完结
-
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
11天前
已完结
-
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
13天前
已完结
-
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
13天前
已完结
-
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial
13天前
已完结
-
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas
14天前
已关闭
-
Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion
17天前
已完结